These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1806624)

  • 1. A controlled study of the efficacy and safety of mianserin and maprotiline in outpatients with major depression.
    Möller HJ; Riehl T; Dietzfelbinger T; Wernicke T
    Int Clin Psychopharmacol; 1991; 6(3):179-92. PubMed ID: 1806624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people.
    Schifano F; Garbin A; Renesto V; De Dominicis MG; Trinciarelli G; Silvestri A; Magni G
    Acta Psychiatr Scand; 1990 Mar; 81(3):289-94. PubMed ID: 2188479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind trial comparing mianserin and maprotiline in depressed inpatients.
    Palha AP; Ferreira L; Abreu-Lima C; Ramalhão C; Fernandes R
    Clin Ther; 1985; 7(5):584-92. PubMed ID: 3902238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled trial of mianserin and maprotiline in primary depressive illness: a preliminary report.
    Edwards JG; Goldie A
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):239S-248S. PubMed ID: 6337611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mianserin and maprotiline as compared to amitriptyline in severe endogenous depression. A new methodological approach to the clinical evaluation of the efficacy of antidepressants.
    Cording-Tömmel C; von Zerssen D
    Pharmacopsychiatria; 1982 Nov; 15(6):197-204. PubMed ID: 7156183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mianserin, maprotiline and intracardiac conduction.
    Edwards JG; Goldie A
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):249S-254S. PubMed ID: 6824556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moclobemide compared with second-generation antidepressants in elderly people.
    De Vanna M; Kummer J; Agnoli A; Gentili P; Lorizio A; Anand R
    Acta Psychiatr Scand Suppl; 1990; 360():64-6. PubMed ID: 2248077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
    Szegedi A; Wetzel H; Angersbach D; Dunbar GC; Schwarze H; Philipp M; Benkert O
    Pharmacopsychiatry; 1997 May; 30(3):97-105. PubMed ID: 9211571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter double-blind study of moclobemide and maprotiline.
    Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
    Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled study of mianserin in moderately to severely depressed outpatients.
    Carman JS; Ahdieh H; Wyatt-Knowles E; Warga E; Panagides J
    Psychopharmacol Bull; 1991; 27(2):135-9. PubMed ID: 1924659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups.
    Steinmeyer EM; Vorbach EU; Arnoldt KH
    Pharmacopsychiatry; 1993 Nov; 26(6):246-53. PubMed ID: 8127929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mianserin, maprotiline and the electroencephalogram.
    Sedgwick EM; Edwards JG
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):255S-259S. PubMed ID: 6824557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparative trial with mianserin and amitriptyline in outpatients with major depressive disorders.
    Feighner JP; Jacobs RS; Jackson RE; Hendrickson G; Merideth CH; O'Meara PD
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):227S-237S. PubMed ID: 6337610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mianserin versus maprotiline in patients with a depressive syndrome.
    Indaco A; Orefice G; Carrieri P
    Acta Neurol (Napoli); 1984 Apr; 6(2):140-6. PubMed ID: 6741655
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression.
    de Jonghe F; Ravelli DP; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Mar; 24(2):62-7. PubMed ID: 1852793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind trial of mianserin and nomifensine in depressed outpatients.
    Hamouz W; Van Dorth R; Pinder RM; Stulemeijer SM
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):219S-225S. PubMed ID: 6337609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine compared with paroxetine in major depression.
    Benkert O; Szegedi A; Kohnen R
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, multicentre study of paroxetine and maprotiline in major depression.
    Schnyder U; Koller-Leiser A
    Can J Psychiatry; 1996 May; 41(4):239-44. PubMed ID: 8726790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.